Sold as Duexis. Every FDA application for this active ingredient: 1 branded and 7 generic. Boxed warning
As of Nov 22, 2026, FDA lists 8 applications for Famotidine; Ibuprofen (sold as Duexis), first approved Apr 23, 2011, with 0 new uses approved and 0 published complete response letters.
| Apr 23, 2011 | DuexisNDA 22519 · New combination | Horizon Therapeutics | 11 | Discontinued |
| Aug 3, 2021 | Ibuprofen and FamotidineANDA 211890 | Alkem Laboratories | 2 | Marketed |
| Oct 29, 2021 | Ibuprofen and FamotidineANDA 211278 | Teva Pharmaceuticals USA | 2 | Discontinued |
| Mar 15, 2023 | Ibuprofen and FamotidineANDA 216814 | Ascent Pharmaceuticals | 2 | Marketed |
| Mar 18, 2024 | Ibuprofen and FamotidineANDA 215925 | Torrent Pharmaceuticals | 1 | Discontinued |
| Mar 22, 2024 | Ibuprofen and FamotidineANDA 203658 | PH Health | 1 | Marketed |
| Feb 20, 2025 | Ibuprofen and FamotidineANDA 218684 | Zydus Lifesciences | 0 | Marketed |
| Jun 30, 2025 | Ibuprofen and FamotidineANDA 219538 | Aurobindo Pharma | 0 | Discontinued |
| Study | Phase | Status | Posted |
|---|---|---|---|
| Paracetamol and Ibuprofen With or Without Famotidine for Calcific Tendinitis of the ShoulderCalcific Tendinitis · University Hospital Dubrava | Not applicable | Not yet recruiting | Apr 20, 2026 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA